| 1 |
Partly verified |
Full text not readStored summary read |
N01 · Evidence conditionWhich existing overall-sleep claim is being carried over?Required |
The selected claim is improved overall sleep quality, originally graded ?. Its note limits this verdict to one sleepiness-on-rising score rather than the broader claim. Absent subclaim score/status/axes are distinguished from parent C50. |
Production observation distinguishing selected/parent, report and endpoint materials in the preserved summary. Detailed original materials remain unverified and existing content review is incomplete; this does not establish completed clinical review or certification. |
Selected subclaim wording/grade and the narrower parent result |
Materials needed: Exact overall-sleep definition, population, time point, direct comparisons and user review of the question boundary are needed. Parent scores are not used to fill subclaim values. Only information requests/research needs are recorded; no new lookup or research is performed in this production. |
| 2 |
Partly verified |
Full text not readStored summary read |
N02 · Evidence conditionWhat sleep condition characterized the participants?Required |
Participants were 64 healthy Japanese adults dissatisfied with sleep quality. Applicability is not newly extended to diagnosed insomnia/sleep disorders or all ages/regions. |
Production observation distinguishing selected/parent, report and endpoint materials in the preserved summary. Detailed original materials remain unverified and existing content review is incomplete; this does not establish completed clinical review or certification. |
Healthy adults dissatisfied with sleep quality |
Materials needed: Actual eligibility/exclusions, baseline sleep/health, age/sex, comorbidities/medication and direct comparisons in other populations are needed. Only information requests/research needs are recorded; no new lookup or research is performed in this production. |
| 3 |
Partly verified |
Full text not readStored summary read |
N03 · Evidence conditionWhat extract exposure was studied?Required |
The original intervention studied 100 mg black soybean seed-coat polyphenol extract after the evening meal for 12 weeks. Original constituent descriptions including proanthocyanidins and epicatechins are preserved; the result is not treated as equivalent to ordinary black soybeans/soy foods or other extracts. |
Production observation distinguishing selected/parent, report and endpoint materials in the preserved summary. Detailed original materials remain unverified and existing content review is incomplete; this does not establish completed clinical review or certification. |
100 mg black soybean seed-coat extract versus ordinary foods |
Materials needed: Original formulation, quantified constituents, product/manufacture, accompanying ingredients and adherence data are needed. Beyond identifying study exposure, no product/extract-intake or sleep instructions are supplied. Only information requests/research needs are recorded; no new lookup or research is performed in this production. |
| 4 |
Partly verified |
Full text not readStored summary read |
N04 · Evidence conditionWhat were the actual placebo and conditions in both arms?Required |
The original records 64 participants assigned 32 each to extract and placebo. Actual placebo composition, blinding/sensory conditions and arm-specific sleep habits/other exposures are unverified. |
Production observation distinguishing selected/parent, report and endpoint materials in the preserved summary. Detailed original materials remain unverified and existing content review is incomplete; this does not establish completed clinical review or certification. |
32/32 allocation and placebo comparison |
Materials needed: Placebo/active implementation, allocation concealment, contact/expectations, concurrent diet/medication and sleep exposures are needed. Findings are not substituted for overall-sleep effects against other comparators. Only information requests/research needs are recorded; no new lookup or research is performed in this production. |
| 5 |
Partly verified |
Full text not readStored summary read |
N05 · Evidence conditionAre 12-week results distinguished from sustained overall sleep?Required |
The original duration was 12 weeks. Details of actual exposure/adherence, discontinuation, measurement schedules, persistence after completion and direct long-term overall-sleep data are unverified. No new cumulative amounts, day counts or long-term efficacy are created. |
Production observation distinguishing selected/parent, report and endpoint materials in the preserved summary. Detailed original materials remain unverified and existing content review is incomplete; this does not establish completed clinical review or certification. |
Original duration, actual exposure and post-study follow-up |
Materials needed: Time-specific overall/factor results, actual exposure, follow-up and discontinuation/recurrence data are needed. Short-term specific scores are not converted into long-term sleep effects. Only information requests/research needs are recorded; no new lookup or research is performed in this production. |
| 6 |
Partly verified |
Full text not readStored summary read |
N06 · Evidence conditionDoes a 64-person FAS1 mean everyone completed follow-up?Required |
The original evidence records 64 randomized participants in FAS1 (32/32). The summary does not establish FAS1 definitions, completion/attrition or time-specific observation/missingness details. Complete 12-week follow-up or identical denominators for every measure are not assumed. |
Production observation distinguishing selected/parent, report and endpoint materials in the preserved summary. Detailed original materials remain unverified and existing content review is incomplete; this does not establish completed clinical review or certification. |
Randomized, FAS1, completer and endpoint-specific denominators |
Materials needed: FAS1 definitions, arm-specific flow, observation/analysis denominators and attrition/missingness reasons/handling are needed. No new attrition counts/rates or repeated-measurement totals are calculated. Only information requests/research needs are recorded; no new lookup or research is performed in this production. |
| 7 |
Partly verified |
Full text not readStored summary read |
N07 · Evidence conditionWhat does the primary rising-sleepiness factor measure?Required |
The original primary endpoint is 12-week change in OSA-MA sleepiness-on-rising score. It is a specific self-reported sleep-scale factor; total scores, other factors and overall sleep are not newly declared the same measure. |
Production observation distinguishing selected/parent, report and endpoint materials in the preserved summary. Detailed original materials remain unverified and existing content review is incomplete; this does not establish completed clinical review or certification. |
12-week change in OSA-MA sleepiness on rising |
Materials needed: OSA-MA version, factors/items, score direction, measurement dates/times and relationships to overall/other scales are needed. Only information requests/research needs are recorded; no new lookup or research is performed in this production. |
| 8 |
Unverified |
Full text not readStored summary read |
N08 · Evidence conditionDoes a specific rising-sleepiness result establish overall sleep?Required |
Original Korean/English text and the subclaim note limit the claim to one rising-sleepiness score rather than overall sleep improvement. Appropriate direct overall-sleep measures, full results and effects are not established within the preserved scope. |
Production observation distinguishing selected/parent, report and endpoint materials in the preserved summary. Detailed original materials remain unverified and existing content review is incomplete; this does not establish completed clinical review or certification. |
Scope of the broader claim and direct outcomes |
Materials needed: Prespecified direct overall-sleep endpoints, full results, denominators, effects/CIs and confirmation are needed. A narrow signal is not promoted into certification of the broader claim. Only information requests/research needs are recorded; no new lookup or research is performed in this production. |
| 9 |
Partly verified |
Full text not readStored summary read |
N09 · Evidence conditionWhich analysis produced P<.05?Required |
The full-FAS1 primary rising-sleepiness score improved versus placebo, P<0.05. This P value is not copied into overall/objective sleep, subgroups or other scales. No exact P value is newly estimated. |
Production observation distinguishing selected/parent, report and endpoint materials in the preserved summary. Detailed original materials remain unverified and existing content review is incomplete; this does not establish completed clinical review or certification. |
Full-FAS1 primary result versus overall sleep |
Materials needed: Original primary analysis/models, denominators, exact effects/CIs, clinical importance and separate overall-sleep data are needed. P alone is not used to derive new magnitudes/CIs. Only information requests/research needs are recorded; no new lookup or research is performed in this production. |
| 10 |
Unverified |
Full text not readStored summary read |
N10 · Evidence conditionAre figure estimates distinguished from values absent in the text?Required |
The original describes estimated marginal means ± standard errors displayed in a figure, with exact group values and 95% CIs absent from the main text. This does not establish that all figures/raw data are unavailable; figures were not newly read or digitized. |
Production observation distinguishing selected/parent, report and endpoint materials in the preserved summary. Detailed original materials remain unverified and existing content review is incomplete; this does not establish completed clinical review or certification. |
Estimated marginal means ± SE versus exact values/CIs |
Materials needed: Original figures, supplementary tables, exact group values, estimation models and effects/CIs are needed. No numerical reading/back-calculation, hypothetical examples or CI calculations are performed. Only information requests/research needs are recorded; no new lookup or research is performed in this production. |
| 11 |
Partly verified |
Full text not readStored summary read |
N11 · Evidence conditionAre change, absolute values and within/between-group contrasts separated?Required |
The endpoint is 12-week change, and the original describes improvement versus placebo in full FAS1. Exact baseline/end values, arm-specific changes, estimands and models are unverified. Within-group improvement is not newly calculated as an additional effect versus placebo. |
Production observation distinguishing selected/parent, report and endpoint materials in the preserved summary. Detailed original materials remain unverified and existing content review is incomplete; this does not establish completed clinical review or certification. |
Estimand for 12-week change |
Materials needed: Arm-specific baseline/end/change values and estimands, baseline adjustment, repeated measurements, missing-data handling and models are needed. No new changes, ratios or effects are calculated. Only information requests/research needs are recorded; no new lookup or research is performed in this production. |
| 12 |
Unverified |
Full text not readStored summary read |
N12 · Evidence conditionWhat is the hierarchy of other sleep and temperature outcomes?Required |
The original counterview distinguishes other sleep/temperature endpoints as secondary outcomes. The summary does not establish complete labels, effects/CIs, significant/null result lists or prespecified hierarchy. Temperature/other factors are not combined as proof of overall sleep. |
Production observation distinguishing selected/parent, report and endpoint materials in the preserved summary. Detailed original materials remain unverified and existing content review is incomplete; this does not establish completed clinical review or certification. |
Primary factor versus secondary sleep/temperature endpoints |
Materials needed: Complete endpoint tables, registry/protocol/SAP, secondary hierarchy, direct endpoint results/denominators and multiplicity plans are needed. Unread materials are not treated as absence/nullity of every outcome. Only information requests/research needs are recorded; no new lookup or research is performed in this production. |
| 13 |
Partly verified |
Full text not readStored summary read |
N13 · Evidence conditionAre male/other subgroup findings distinguished from full-population results?Required |
The original explains that male-only positive and other subgroup analyses did not replace the full-FAS1 primary positive result or broaden it into overall sleep improvement. Subgroup counts, exact effects and interactions are unverified. |
Production observation distinguishing selected/parent, report and endpoint materials in the preserved summary. Detailed original materials remain unverified and existing content review is incomplete; this does not establish completed clinical review or certification. |
Full FAS1 versus subgroup analyses |
Materials needed: Original subgroup prespecification, denominators/effects/CIs, interactions, multiplicity and relationships to full analyses are needed. Subgroups are not counted as added independent trials/participants. Only information requests/research needs are recorded; no new lookup or research is performed in this production. |
| 14 |
Unverified |
Full text not readStored summary read |
N14 · Evidence conditionWere multiplicity and registry plans verified in detail?Required |
The original used only the full-FAS1 primary analysis as verdict evidence. Total tests, adjustments, hierarchy/changes across sleep/temperature and subgroup analyses are unverified; UMIN/protocol records were not read in this production. Adjusted results are not newly judged. |
Production observation distinguishing selected/parent, report and endpoint materials in the preserved summary. Detailed original materials remain unverified and existing content review is incomplete; this does not establish completed clinical review or certification. |
Testing conditions for primary/secondary/subgroup analyses |
Materials needed: Actual UMIN000051261 registry records, protocol/SAP, all endpoints/multiplicity, public/amendment dates and the original report are needed. No new adjusted P values or grades. Only information requests/research needs are recorded; no new lookup or research is performed in this production. |
| 15 |
Unverified |
Full text not readStored summary read |
N15 · Evidence conditionAre self-report results being transferred to objective sleep?Required |
The original evidence concerns the rising-sleepiness factor of a self-reported sleep scale. Direct objective PSG/activity-recording, sleep duration/efficiency, onset and awakening results are not provided within the preserved materials. Unread records do not establish that these tests were unmeasured. |
Production observation distinguishing selected/parent, report and endpoint materials in the preserved summary. Detailed original materials remain unverified and existing content review is incomplete; this does not establish completed clinical review or certification. |
Subjective scales versus objective sleep |
Materials needed: Objective instruments/measurements, direct results separate from subjective scales, times/denominators and effects/CIs are needed. Other physiological measures do not establish overall sleep. Only information requests/research needs are recorded; no new lookup or research is performed in this production. |
| 16 |
Partly verified |
Full text not readStored summary read |
N16 · Evidence conditionAre constituent/temperature explanations direct sleep evidence?Supplementary |
Proanthocyanidins and epicatechins describe original extract constituents; temperature results are described as secondary. Constituents, mechanisms and temperature do not newly establish overall/clinical sleep effects. |
Production observation distinguishing selected/parent, report and endpoint materials in the preserved summary. Detailed original materials remain unverified and existing content review is incomplete; this does not establish completed clinical review or certification. |
Constituent identity and mechanisms versus overall-sleep effects |
Materials needed: Formulation/quantification and mechanism data should be linked separately from direct sleep endpoints/effects. No efficacy expansion beyond the original primary/secondary conditions. Only information requests/research needs are recorded; no new lookup or research is performed in this production. |
| 17 |
Partly verified |
Full text not readStored summary read |
N17 · Harm-information gaps supplementing the efficacy tableWhat is the scope of the 12-week adverse-event narrative?Supplementary |
The original states that no adverse events were reported in the 12-week trial and explicitly says the small 64-person trial cannot exclude rare or long-term harms. This is not expanded into zero harms of every kind or long-term safety. |
Production observation distinguishing selected/parent, report and endpoint materials in the preserved summary. Detailed original materials remain unverified and existing content review is incomplete; this does not establish completed clinical review or certification. |
Small-trial reporting versus rare/long-term harms |
Materials needed: AE collection, arm-specific exposure/observation, harm denominators, discontinuation/relatedness and rare/long-term data are needed. No new harm rates or extract/product/sleep-management instructions. Only information requests/research needs are recorded; no new lookup or research is performed in this production. |
| 18 |
Partly verified |
Full text not readStored summary read |
N18 · Evidence conditionWhat materials were actually read in this work?Required |
The complete parent JSON was read for production and preserved in its original form. Summary reading concerns the preserved summary; external abstracts, full texts, registration and protocol/SAP remain unread in this work. URL/bibliography presence is not upgraded into external reading. |
Production observation distinguishing selected/parent, report and endpoint materials in the preserved summary. Detailed original materials remain unverified and existing content review is incomplete; this does not establish completed clinical review or certification. |
Preserved JSON summary and external-reading status |
Materials needed: Materials for users to record actual external acquisition/reading scope, versions and timing. No current link/click/access tests. Only material requests/research needs are recorded; no current lookup or research execution. |
| 19 |
Partly verified |
Full text not readStored summary read |
N19 · Evidence conditionAre registration, public dates, plans and current reading distinct?Required |
The original evidence/Korean text supplies UMIN000051261; the citation has no registry identifier/official registry URL. Actual registration/start dates, versions, prospective status and plan comparisons are unverified in this production. Official URLs are not guessed. |
Production observation distinguishing selected/parent, report and endpoint materials in the preserved summary. Detailed original materials remain unverified and existing content review is incomplete; this does not establish completed clinical review or certification. |
Original registration information and detailed plans/access |
Materials needed: Original registration texts/versions, public/start/change dates, endpoint/analysis and report-linkage materials. Only historical narratives are preserved; no current prespecification/access certification. Only material requests/research needs are recorded; no current lookup or research execution. |
| 20 |
Unverified |
Full text not readStored summary read |
N20 · Evidence conditionWere protocol/SAP and endpoint/multiplicity plans acquired?Required |
The original registration identifier, historical cross-checking and primary/secondary narratives are preserved. Individual protocol/SAP originals, versions/dates, complete endpoints/analyses/multiplicity and plan changes were not read in this work. |
Production observation distinguishing selected/parent, report and endpoint materials in the preserved summary. Detailed original materials remain unverified and existing content review is incomplete; this does not establish completed clinical review or certification. |
Advance plan, change and analysis materials |
Materials needed: Protocol, SAP, revision history, complete endpoints/estimands/missingness, multiple comparisons, public dates and paper-comparison materials. Unread external materials are not assumed to mean absent documents. Only material requests/research needs are recorded; no current lookup or research execution. |
| 21 |
Partly verified |
Full text not readStored summary read |
N21 · Evidence conditionAre company funding, product support, employee authors and research roles separate?Required |
The original distinguishes the no-specific-funding declaration, three Fujicco employee authors R.A./T.M./K.M., study-food provision to the contract site and employee involvement in conceptualization, methods, analysis, data management and drafting. No specific cash funding does not mean no COI or company involvement. |
Production observation distinguishing selected/parent, report and endpoint materials in the preserved summary. Detailed original materials remain unverified and existing content review is incomplete; this does not establish completed clinical review or certification. |
Four categories of company involvement and other support |
Materials needed: Separate originals for company cash funding, product/food manufacturing support, author employment/contractor relationships, design/analysis/data control and other support/COI. The original independence axis is not used as new certification. Only material requests/research needs are recorded; no current lookup or research execution. |
| 22 |
Partly verified |
Full text not readStored summary read |
N22 · Evidence conditionAre narrow positive results, broad-claim gaps and unverified materials distinct?Required |
The positive full-FAS1 primary rising-sleepiness P<.05 is distinguished from the unverified overall-sleep claim and absent exact effects/CIs in the main text. |
Production observation distinguishing selected/parent, report and endpoint materials in the preserved summary. Detailed original materials remain unverified and existing content review is incomplete; this does not establish completed clinical review or certification. |
Direct endpoints and access/reporting limitations |
Materials needed: Materials verifying question-specific actual measurements/definitions, original tables/denominators, plans and actual access scope. Unread is not substituted for unreported, zero studies or zero effect. Only material requests/research needs are recorded; no current lookup or research execution. |
| 23 |
Partly verified |
Full text not readStored summary read |
N23 · Evidence conditionAre reports, trials, people, repeated measures and sibling sheets distinct?Required |
Parent 2978 and the existing sibling sheets share the same Akagi 2025 report and 64-person/12-week trial context. The same people, arms, times, factors, subgroups, citation and sibling sheets are not added as new independent trials/participants. One current report link does not certify unique trial/participant counts. |
Production observation distinguishing selected/parent, report and endpoint materials in the preserved summary. Detailed original materials remain unverified and existing content review is incomplete; this does not establish completed clinical review or certification. |
Document linkage versus unique trials/participants |
Materials needed: Original registration/report, actual cohort/analysis, endpoint/time-point and repeated-measure relationships. Unique trial counts and unique participant totals remain unrecorded. Only material requests/research needs are recorded; no current lookup or research execution. |
| 24 |
Unverified |
Full text not readStored summary read |
N24 · Evidence conditionIs there evidence of separate independent confirmation?Supplementary |
Parent replication R1 and independence I0 are preserved. The same report, subgroup, scale, repeated days or sibling sheets are not certified as new independent efficacy/harm replications. |
Production observation distinguishing selected/parent, report and endpoint materials in the preserved summary. Detailed original materials remain unverified and existing content review is incomplete; this does not establish completed clinical review or certification. |
Original R1/I0 versus independent replication |
Materials needed: Confirmatory materials showing selected-question advance plans, separate populations/comparators, direct endpoints/denominators, effects/CIs, duration/funding and author relationships. No current search or independence judgment. Only material requests/research needs are recorded; no current lookup or research execution. |
| 25 |
Partly verified |
Full text not readStored summary read |
N25 · Evidence conditionAre selected-subclaim and parent scores/axes preserved?Required |
Selected grade/note and Korean/English claim wording are preserved, with absent subclaim score/status/axes left unrecorded. Parent C50, good safety and B/P/R1/I0/E+, bias axis and unrecorded precision are parent context, not a score for the selected row. |
Production observation distinguishing selected/parent, report and endpoint materials in the preserved summary. Detailed original materials remain unverified and existing content review is incomplete; this does not establish completed clinical review or certification. |
Subclaim grade/note, absent fields and parent context |
Materials needed: User subclaim/parent-boundary review and actual correction materials. No new score/grade or official RoB 2/GRADE certification. Only material-request/research needs are recorded; no search/research was performed in this production. |
| 26 |
Partly verified |
Full text not readStored summary read |
N26 · Evidence conditionAre Korean/English wording and absent structured fields preserved?Required |
Parent Korean/English text, evidence/citation lists, axes and original selected-subclaim wording are preserved in the complete summary. Korean/English classification fields are absent; no new fields are filled in the original materials. External English papers were not compared. |
Production observation distinguishing selected/parent, report and endpoint materials in the preserved summary. Detailed original materials remain unverified and existing content review is incomplete; this does not establish completed clinical review or certification. |
Wording in both languages and absent classification fields |
Materials needed: Materials for content review of bilingual terms, endpoints/durations, absent fields and selected scope. Production explanations remain distinct from original wording. Only material requests/research needs are recorded; no current lookup or research execution. |
| 27 |
Partly verified |
Full text not readStored summary read |
N27 · Evidence conditionAre reference dates, corrections, historical cross-checking and production dates distinct?Required |
Original reference date 2026-08-26, empty corrections/deliberation and grade-decision cross-check narratives are preserved. This history is not current condition freezing/application, production date or completed content review. |
Production observation distinguishing selected/parent, report and endpoint materials in the preserved summary. Detailed original materials remain unverified and existing content review is incomplete; this does not establish completed clinical review or certification. |
Original 2026-08-26 versus production/application events |
Materials needed: When new materials/corrections arise, materials for separate updates to originals, events, conditions/observations and verdict decisions. Historical narratives are not used as new clinical review. Only material requests/research needs are recorded; no current lookup or research execution. |
| 28 |
Unverified |
Full text not readStored summary read |
N28 · Evidence conditionWhat direct materials could fill the selected gaps?Supplementary |
Confirming the overall-sleep claim requires information directly defining its overall/objective endpoints; the rising-sleepiness factor, temperature or subgroups do not substitute for this. |
Production observation distinguishing selected/parent, report and endpoint materials in the preserved summary. Detailed original materials remain unverified and existing content review is incomplete; this does not establish completed clinical review or certification. |
Definitions, direct endpoints, denominators/effects/CIs and plans |
Materials needed: Question-matched advance direct comparisons, overall/symptom-specific denominators, estimands/CIs, measurement/missingness, multiplicity and separate confirmation/long-term harms. Only need is recorded; no current lookup or clinical study. Only material requests/research needs are recorded; no current lookup or research execution. |
| 29 |
Partly verified |
Full text not readStored summary read |
N29 · Evidence conditionAre production, user review and implementation instructions distinct?Supplementary |
This is table-content production from the preserved summary. Existing content and question-boundary review remain incomplete, and candidate pending/eligibility flags are preserved as history. Existing review status is recorded as it stands. |
Production observation distinguishing selected/parent, report and endpoint materials in the preserved summary. Detailed original materials remain unverified and existing content review is incomplete; this does not establish completed clinical review or certification. |
Production request, candidate history and content-review responsibility |
Materials needed: Existing content review and later actual-material/correction work. The historical production record did not perform clinical-original comparison, external access, new calculations, grade changes or product/drink-consumption, sleep/cold-management, infection-prevention or treatment-replacement instructions. Only material requests/research needs are recorded; no current lookup or research execution. |